3rd ESCMID Conference on Vaccines - Vaccines for Mutual Protection


6 - 8 March 2015, Lisbon, Portugal

Poster Presentations

Chlamydial Type III Secretion Proteins as Novel Vaccine Candidates. 

David Bulir 

Epidemiology of adult pneumococcal meningitis in the early post PCV era; A nation-wide study, Israel 

Gili Regev-Yochay 

Development of Pneumococcal-Typhoid Bivalent Vaccine 

Neha Kothari 

Vaccine coverage and determinants of incomplete vaccination in children aged 12-23 months in Dschang, West Cameroon: a cross-sectional survey during a Polio outbreak.

Alessandro Miglietta 

Awareness of Human Papillomavirus (HPV) infection and willigness to HPV vaccination among males at risk for sexually transmitted infections 

Maria Gabriella Dona´ 

Epidemiology of invasive pneumococcal disease in adults following introduction of conjugate pneumococcal vaccine; experience of a single 

Corinna Sadlier 

Downregulation of NK cell activity by H. pylori LPS - a way to induce tolerance ? 

Karolina Rudnicka 

The impact of influenza vaccination on the activation and apoptosis of immune cells in children with allergic diseases 

Vilya Bulgakova 

Extension of the United Kingdom Influenza Immunisation Programme 2013/2014 to Children and the Implications for High-Risk Group Uptake 

Sankarasubramanian Rajaram 

Hepatitis A: universal vaccination for adult travelers? 

Sónia Duarte Rocha 

Meningococcal vaccination strategy in the Czech Republic 

Pavla Krizova 

Seasonal and pandemic influenza vaccination coverage in pregnant women in Spain. Are we forgetting this influenza high-risk group? 

Luz Maria Vilca 

Risk Factors Associated for Community-Acquired Pneumonia among Hospitalized Patients: the Risk Stacking Impact 

Alejandro Cané

Seroprevalence of antibodies against the virus Measles, Mumps and Rubella in the student population of the Area Health Serrania de Málaga, Spain 

Maria Jesús 

Human papillomavirus vaccination in Portugal, October 2008 to June 2014 

Joana Cortez

Effective measles elimination strategy in Portugal 

Teresa Fernandes 

A Randomized, Double-Blind, Phase III Trial to Assess the Immunogenicity and Safety of NBP606, a new 13-valent pneumococcal conjugate vaccine

Myoung-don OH 

Pneumococcal conjugate vaccines - impact in the Czech Republic 

Jana Kozakova 

Live Enterovirus Vaccines as oncolytic agents applicable for cancer therapy 

Demina A.V. 

Seroprevalence HVB and knowledge about Hepatitis B vaccine in pregnancy in Abidjan_Cote D’Ivoire 

Kouassi-M´Bengue A 

Measles and Rubella Elimination in Italy: Parvovirus B19 in the differential diagnosis 

Melissa Baggieri 

Evaluation of the Admission Reasons and the Response Rates of the HBV Vaccination at the Adult Vaccination Polyclinic 

Sukran Kose 

Serotypes of Streptococcus pneumoniae from children with tuberculosis and tuberculosis hospital staff 

Julia Skurikhina 

Recombinant Trichina Spiralis 53kDa Protein Directly Activates Macrophages in M2 Pattern in vitro. 

Zhongfu Ma 

Serotype replacement – a challenge to pneumococcal conjugate vaccine efficacy 

Radka Komitova 

Barriers and Motivators of Seasonal Influenza vaccine uptake between Iranian Healthcare workers during 2012/2013 season 

Mohammad Darvishi 

An analysis of government immunization program expenditures in lower and lower middle income countries 2006-12 

Alice Abou Nader 

Colonisation of the pharynx by s.pneumoniae in older children and adolescents in an area characterised by limited pneumococcal vaccination coverage 

Claudia Tagliabue